Monday, October 19, 2015

Valeant Raises Full-Year Guidance

Valeant Pharmaceuticals International further lifted its full-year outlook after the drug company beat earnings expectations in the latest quarter.

from WSJ.com: US Business http://ift.tt/1PsYu4D
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)